CureMint Funding: How Much Did They Raise & Key Investors

How Much Did CureMint Raise?
Funding & Key Investors

CureMint, a specialized provider of dental procurement software, has successfully secured significant capital to bolster its market presence. The company has reached a total funding milestone of $4.7M, reflecting strong investor confidence in its ability to modernize purchasing workflows for dental organizations. This latest injection of capital, totaling $1.2M, marks a major strategic investment that positions the firm to accelerate its operational scaling and enhance its platform capabilities across North America.

The funding trajectory, which began with early-stage backing in 2021, underscores a consistent growth narrative. By securing this recent financing, CureMint is well-positioned to further penetrate the dental technology sector, providing dental practices with the necessary tools to optimize accounts payable processes and achieve greater fiscal transparency.

What is CureMint?

CureMint

Software

Enterprise Resource Planning (ERP)

Supply Chain Management (SCM) Software

CureMint operates at the intersection of healthcare technology and B2B software, offering a robust procurement platform tailored specifically for the dental industry. The company addresses critical pain points in dental practice management, such as fragmented purchasing processes and inefficient accounts payable workflows. By centralizing procurement, CureMint enables dental organizations to gain granular visibility into their spending, reduce overhead costs, and implement automated workflows that drive operational efficiency. Its market position is defined by a focus on customer success and a seamless onboarding experience, making it a vital partner for dental teams looking to modernize their supply chain management.

How much funding has CureMint raised?

CureMint has raised a total of $4.7M across 2 funding rounds:

2021

Angel/Seed

$3.5M

2023

Other Financing Round

$1.2M

Angel/Seed (2021): $3.5M with participation from VentureSouth, Cofounders Capital, Front Porch Ventures, and Stout Street Capital

Other Financing Round (2023): $1.2M, investors not publicly disclosed

Key Investors in CureMint

VentureSouth

VentureSouth is an early-stage investment firm focused on providing capital and expertise to startups in the Southeastern United States through its angel investment network and funds.

Cofounders Capital

Cofounders Capital is a venture capital fund that specializes in seed stage investments, focusing primarily on B2B software companies located in the Southeast region.

Stout Street Capital

Stout Street Capital is a Denver-based venture capital firm that specializes in early-stage technology companies, with a specific preference for B2B SaaS business models.

What's next for CureMint?

With the recent infusion of capital, CureMint is poised to enter a new phase of enterprise-level expansion. The strategic roadmap likely involves deepening its software integrations, expanding its vendor network, and enhancing its data analytics capabilities to provide more actionable insights for dental practices. As the company scales, the focus will remain on maintaining its competitive edge in the B2B SaaS space, ensuring that its procurement tools remain the standard for dental organizations seeking to streamline their financial operations and improve bottom-line performance.

See full CureMint company page

See More Financial Insights